TPM4 and glioma: Assessment of the prognostic value of TPM4 expression in glioma patients subgrouped by histological type, sex, IDH mutation status, WHO grade, chromosome 1p/19q codeletion, and patient age showed that high expression of TPM4 was associated with poorer prognosis in all of these groups (Fig. 4A–C).